2019 Vol.37, N°5 - Suppl.120 - Table of contents
New concepts in osteoarthritis
purchase complete issue
Introduction
CER12863
2019,37,5,Suppl.120
Pg. 0002
Free to view
New concepts in osteoarthritis
A.-M. Malfait, T. Pincus
Epidemiology
CER12785
2019,37,5,Suppl.120
Pg. 0003-0006
Free to view
Osteoarthritis is a serious disease
G.A. Hawker
CER12800
2019,37,5,Suppl.120
Pg. 0007-0017
Free to view
Osteoarthritis is as severe as rheumatoid arthritis: evidence over 40 years according to the same measure in each disease
T. Pincus, I. Castrejon, Y. Yazici, K.A. Gibson, M.J. Bergman, J.A. Block
CER12813
2019,37,5,Suppl.120
Pg. 0018-0023
Free to view
Low socioeconomic status and patient questionnaires in osteoarthritis: challenges to a “biomedical model” and value of a complementary “biopsychosocial model”
T. Pincus, I. Castrejon
CER12789
2019,37,5,Suppl.120
Pg. 0024-0030
Free to view
Knee and hip osteoarthritis as predictors of premature death: a review of the evidence
R.J. Cleveland, A.E. Nelson, L.F. Callahan
CER12748
2019,37,5,Suppl.120
Pg. 0031-0039
Free to view
Public Health Interventions for Osteoarthritis - updates on the Osteoarthritis Action Alliance’s efforts to address the 2010 OA Public Health Agenda Recommendations
L.F. Callahan, K.R. Ambrose, A.L. Albright, M. Altpeter, Y.M. Golightly, K.F. Huffman, A.E. Nelson, S.E. Weisner
Pathophysiology
CER12743
2019,37,5,Suppl.120
Pg. 0040-0047
Free to view
The function of microRNAs in cartilage and osteoarthritis
T.E. Swingler, L. Niu, P. Smith, P. Paddy, L. Le, M.J. Barter, D.A. Young, I.M. Clark
CER12605
2019,37,5,Suppl.120
Pg. 0048-0056
Free to view
Danger signals and inflammaging in osteoarthritis
M. Millerand, F. Berenbaum, C. Jacques
CER12757
2019,37,5,Suppl.120
Pg. 0057-0063
Free to view
Innate inflammation and synovial macrophages in osteoarthritis pathophysiology
T.M. Griffin, C.R. Scanzello
CER12718
2019,37,5,Suppl.120
Pg. 0064-0072
Free to view
Phenotypes of osteoarthritis: current state and future implications
L.A. Deveza, A.E. Nelson, R.F. Loeser
Measurement
CER12762
2019,37,5,Suppl.120
Pg. 0073-0087
Free to view
Biochemical markers in osteoarthritis with lessons learned from osteoporosis
M.A. Karsdal, K. Henriksen, A.C. Bay-Jensen
CER12778
2019,37,5,Suppl.120
Pg. 0088-0095
Free to view
Magnetic resonance imaging assessment of knee osteoarthritis: current and developing new concepts and techniques
D. Hayashi, F.W. Roemer, A. Guermazi
CER12717
2019,37,5,Suppl.120
Pg. 0096-0099
Free to view
Identifying pain susceptibility phenotypes in knee osteoarthritis
L.C. Carlesso, T. Neogi
CER12802
2019,37,5,Suppl.120
Pg. 0100-0111
Free to view
Patient questionnaires in osteoarthritis: what patients teach doctors about their osteoarthritis on a multidimensional health assessment questionnaire (MDHAQ) in clinical trials and clinical care
T. Pincus, J. Schmukler, I. Castrejon
Specific organs
CER12749
2019,37,5,Suppl.120
Pg. 0112-0117
Free to view
Physical therapy for patients with knee and hip osteoarthritis: supervised, active treatment is current best practice
S.T. Skou, E.M. Roos
CER12765
2019,37,5,Suppl.120
Pg. 0118-0123
Free to view
The powerful placebo effect in osteoarthritis
W. Zhang
CER12738
2019,37,5,Suppl.120
Pg. 0124-0129
Free to view
Treating osteoarthritis pain: recent approaches using pharmacological therapies
A. Ghouri, P.G. Conaghan
CER12781
2019,37,5,Suppl.120
Pg. 0130-0134
Free to view
The “elusive DMOAD”: Aggrecanase inhibition from laboratory to clinic
A.-M. Malfait, M.D. Tortorella
CER12727
2019,37,5,Suppl.120
Pg. 0135-0140
Free to view
Disease modification in osteoarthritis: are we there yet?
W.M. Oo, D.J. Hunter